SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure
Why the study?
Does SERCA2a gene therapy reduce sarcoplasmic reticulum calcium leak and ventricular arrhythmias in a model of chronic heart failure?
Population
In vitro and in vivo models of chronic heart failure (failing hearts)
Design
Preclinical
Authors
Discussion
Loading...
Member takes
Implication
Hypothesis-generating for SERCA2a gene therapy in heart failure; leaves open clinical translation to reduce ventricular arrhythmias.
Structured PICO
Does SERCA2a gene therapy reduce sarcoplasmic reticulum calcium leak and ventricular arrhythmias in a model of chronic heart failure?
P
Population
In vitro and in vivo models of chronic heart failure (failing hearts)
I
Intervention
SERCA2a gene therapy (gene transfer)
O
Outcome
Sarcoplasmic reticulum (SR) calcium leak and ventricular arrhythmias (spontaneous and catecholamine-induced)surrogate
SERCA2a gene transfer reduces sarcoplasmic reticulum calcium leak and ventricular arrhythmias in a heart failure model, suggesting a potential novel antiarrhythmic strategy.
Cite This Study
Lyon et al. (2011) studied this question.